SYUP Stock Chart & Stats
$0.01
>-$0.01(-33.33%)
At close: 4:00 PM EDT
$0.01
>-$0.01(-33.33%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume3.33M
Average Volume (3M)100.00
Market Cap
$15.92K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)<0.1
Beta-0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding79,604,760
10 Day Avg. Volume100
30 Day Avg. Volume100
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SYUP FAQ
What was ANBC Inc’s price range in the past 12 months?
ANBC Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is ANBC Inc’s market cap?
ANBC Inc’s market cap is $15.92K.
When is ANBC Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ANBC Inc’s earnings last quarter?
Currently, no data Available
Is ANBC Inc overvalued?
According to Wall Street analysts ANBC Inc’s price is currently Overvalued.
Does ANBC Inc pay dividends?
ANBC Inc does not currently pay dividends.
What is ANBC Inc’s EPS estimate?
ANBC Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ANBC Inc have?
ANBC Inc has 79,604,760 shares outstanding.
What happened to ANBC Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ANBC Inc?
Currently, no hedge funds are holding shares in SYUP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ANBC Inc
Shanghai Yutong Pharma, Inc., a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of China. Their diverse product portfolio addresses a wide range of health concerns. Noteworthy offerings include Qilisheng, crafted to strengthen the immune system and promote overall vitality. Oral solutions such as Qi-ju-di-huang are formulated to support kidney and liver function, while Qing-re-jie-du serves to reduce fever and alleviate heat. Sheng-mai-yin is designed to conserve vital energy and replenish bodily fluids, and Xiao-qing-long provides relief from coughs and difficulty breathing. The company also produces various syrups: Shen-bao targets the treatment of impotence and spermatorrhoea; Ban-xia offers cough suppression; and Gan-mao-zhi-ke combats symptoms of the flu, coughs, and nasal congestion. Further herbal preparations encompass Ban-lan-gen for common cold and influenza relief; Gan-mao-qing-re, which helps to mitigate minor body aches, pains, and fever; Huang-dan-yin-chen, utilized in managing jaundice and infectious hepatitis; and Liu-shen-qu, prescribed for instances of vomiting and dysentery. These pharmaceutical goods are supplied to distributors via a wholesale model.